Northwest Biotherapeutics, Inc., a biotechnology company, engages in the development of personalized immune therapies for cancer. The company develops DCVax, a platform technology which uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. It also engages in the...
7 insider purchases on record · latest filing 2015-04-30.
Insiders have also filed 24 sale transactions at NWBO.